A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer
Condition: Premenopausal Breast CancerInterventions: Drug: TAP-144-SR(6M); Drug: TAP-144-SR(3M)Sponsor: TakedaCompleted - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Research | Study